ACC Highlights 2020 - What You Need To Know
Details & Video
Program details and agenda: Select TABS on the left (computer) or SCROLL DOWN (phone)
Overview & Objectives
This program was developed by the Canadian Collaborative Research Network and covers the key clinical trial findings and their implications from ACC 2020. This program is intended for cardiovascular specialists and family physicians from across Canada.
This program is NOT accredited.
Mainpro+ participants may earn certified credits by completing a Linking Learning Exercise.
Specialist participants may claim Section 2 credits (up to 2 credits per hour) following completion of a personal learning project (PLP) under Section 2: Self-Learning Activities within the MAINPORT ePortfolio.
|- New data from PARAGON-HF|
|Peripheral artery disease|
|- COMPASS DM|
|- Homozygous FH|
|- EPA levels in REDUCE-IT|
|- New data from ODYSSEY Outcomes|
|- Evolocumab for HIV patients|
|Structural heart disease|
|- Updates in TAVR|
Amgen Canada Inc.
Bristol Meyers Squibb